Allan Reine is Chief Financial Officer of Foghorn Therapeutics Inc.. Currently has a direct ownership of 53,784 shares of FHTX, which is worth approximately $434,036. The most recent transaction as insider was on Aug 09, 2021, when has been sold 26,892 shares (Common Stock) at a price of $3.72 per share, resulting in proceeds of $100,038. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.8K
0% 3M change
0% 12M change
Total Value Held $434,036

Allan Reine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2021
BUY
Exercise of conversion of derivative security
$100,038 $3.72 p/Share
26,892 Added 33.33%
53,784 Common Stock

Also insider at

PRME
Prime Medicine, Inc.
AR

Allan Reine

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on FHTX

Follow Foghorn Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FHTX shares.

Notify only if

Insider Trading

Get notified when an Foghorn Therapeutics Inc. insider buys or sells FHTX shares.

Notify only if

News

Receive news related to Foghorn Therapeutics Inc.

Track Activities on FHTX